Market Tracker

06/23 5:16pm ET

Incyte Corp (NASDAQ:INCY)

136.28
Delayed Data
As of Jun 23
 +0.65 / +0.48%
Today’s Change
71.75
Today|||52-Week Range
153.15
+35.91%
Year-to-Date

Today’s Trading

Previous close135.63
Today’s open135.34
Day’s range133.83 - 136.86
Volume1,790,344
Average volume (3 months)2,541,098
Market cap$27.9B
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+1,700.00%
Earnings growth (this year)-240.51%
Earnings growth (next 5 years)+98.90%
Revenue growth (last year)+46.70%
P/E ratioNM
Price/Sales17.60
Price/Book61.35

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-0.16-0.13%
ZTSZoetis Inc-0.73-1.15%
VRTXVertex Pharmaceutica...-2.03-1.50%
BAXBaxter International...+0.70+1.15%
Data as of 4:01pm ET, 06/23/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.00
Annual revenue (last year)$1.1B
Annual profit (last year)$104.2M
Net profit margin9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts